561 related articles for article (PubMed ID: 27525679)
1. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.
Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
4. Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
Lazaris A; Coleman DC; Kearns AM; Pichon B; Kinnevey PM; Earls MR; Boyle B; O'Connell B; Brennan GI; Shore AC
J Antimicrob Chemother; 2017 Dec; 72(12):3252-3257. PubMed ID: 28961986
[TBL] [Abstract][Full Text] [Related]
5. Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance.
Gawryszewska I; Żabicka D; Hryniewicz W; Sadowy E
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1279-1286. PubMed ID: 28197728
[TBL] [Abstract][Full Text] [Related]
6. Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: A single-centre study in South Korea.
Cho SY; Kim HM; Chung DR; Kim SH; Huh HJ; Kang CI; Peck KR; Lee NY; Song JH
J Glob Antimicrob Resist; 2018 Mar; 12():44-47. PubMed ID: 28941790
[TBL] [Abstract][Full Text] [Related]
7. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
[TBL] [Abstract][Full Text] [Related]
8. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.
Wang Y; Lv Y; Cai J; Schwarz S; Cui L; Hu Z; Zhang R; Li J; Zhao Q; He T; Wang D; Wang Z; Shen Y; Li Y; Feßler AT; Wu C; Yu H; Deng X; Xia X; Shen J
J Antimicrob Chemother; 2015 Aug; 70(8):2182-90. PubMed ID: 25977397
[TBL] [Abstract][Full Text] [Related]
9. Detection of oxazolidinone and phenicol resistant enterococcal isolates from duck feces and carcasses.
Na SH; Moon DC; Choi MJ; Oh SJ; Jung DY; Kang HY; Hyun BH; Lim SK
Int J Food Microbiol; 2019 Mar; 293():53-59. PubMed ID: 30640000
[TBL] [Abstract][Full Text] [Related]
10. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
[TBL] [Abstract][Full Text] [Related]
11. Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome Sequencing.
Abbo L; Shukla BS; Giles A; Aragon L; Jimenez A; Camargo JF; Simkins J; Sposato K; Tran TT; Diaz L; Reyes J; Rios R; Carvajal LP; Cardozo J; Ruiz M; Rosello G; Cardona AP; Martinez O; Guerra G; Beduschi T; Vianna R; Arias CA
Clin Infect Dis; 2019 Jul; 69(2):259-265. PubMed ID: 30339217
[TBL] [Abstract][Full Text] [Related]
12. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
[TBL] [Abstract][Full Text] [Related]
13. Detection of the classical G2576U mutation in linezolid resistant Staphylococcus aureus along with isolation of linezolid resistant Enterococcus faecium from a patient on short-term linezolid therapy: first report from India.
Rai S; Niranjan DK; Kaur T; Singh NP; Hada V; Kaur IR
Indian J Med Microbiol; 2015; 33(1):21-4. PubMed ID: 25559997
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci.
Silva-Del Toro SL; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 May; 85(1):102-4. PubMed ID: 26971179
[TBL] [Abstract][Full Text] [Related]
15. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
[TBL] [Abstract][Full Text] [Related]
16. Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.
Sahm DF; Deane J; Bien PA; Locke JB; Zuill DE; Shaw KJ; Bartizal KF
Diagn Microbiol Infect Dis; 2015 Feb; 81(2):112-8. PubMed ID: 25488274
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
[TBL] [Abstract][Full Text] [Related]
18. Detection of novel oxazolidinone and phenicol resistance gene optrA in enterococcal isolates from food animals and animal carcasses.
Tamang MD; Moon DC; Kim SR; Kang HY; Lee K; Nam HM; Jang GC; Lee HS; Jung SC; Lim SK
Vet Microbiol; 2017 Mar; 201():252-256. PubMed ID: 28284617
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
20. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
Rybak JM; Marx K; Martin CA
Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
